SEARCH

SEARCH BY CITATION

References

  • Bátkai S, Járai Z, Wagner JA, Goparaju SK, Varga K, Liu J, Wang L, Mirshahi F, Khanolkar AD, Makriyannis A, Urbascheck R, Garcia N Jr, Sanyal AJ & Kunos G (2001). Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 7, 827832.
  • Bonz A, Laser M, Kullmer S, Kniesch S, Babin-Ebell J, Popp V, Ertl G & Wagner JA (2003). Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle. J Cardiovasc Pharmacol 41, 657664.
  • Di Marzo V, Bisogno T, Melck D, Ross R, Brockie H, Stevenson L, Pertwee R & De Petrocellis L (1998). Interactions between synthetic vanilloids and the endogenous cannabinoids system. FEBS Lett 436, 449454.
  • Gebremedhin D, Lange AR, Campbell WB, Hillard CJ & Harder DR (1999). Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current. Am J Physiol 266, H2085H2093.
  • Grainger J & Boachie-Ansah G (2001). Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels. Br J Pharmacol 134, 10031012.
  • Harris D, McCulloch AI, Kendall DA & Randall MD (2002). Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed. J Physiol 539, 893902.
  • Hillard CJ (2000). Endocannabinoids and vascular function. J Pharmacol Exp Ther 294, 2732.
  • Ishac EJ, Jiang L, Lake KD, Varga K, Abood ME & Kunos G (1996). Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br J Pharmacol 118, 20232028.
  • Járai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, Razdan RK, Zimmer A & Kunos G (1999). Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci U S A 96, 1413614141.
  • Kapoor K, Arulmani U, Heiligers JP, Garrelds IM, Willems EW, Doods H, Villalon CM & Saxena PR (2003). Effects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigs. Br J Pharmacol 140, 329338.
  • Kass DA, Maughan WL, Guo ZM, Kono A, Sunagawa K & Sagawa K (1987). Comparative influence of load versus inotropic states on indexes of ventricular contractility: experimental and theoretical analysis based on pressure-volume relationships. Circulation 76, 14221436.
  • Kunos G, Batkai S, Offertaler L, Mo F, Liu J, Karcher J & Harvey-White J (2002). The quest for a vascular endothelial cannabinoids receptor. Chem Physics Lipids 121, 4556.
  • Lake KD, Compton DR, Varga K, Martin BR & Kunos G (1997a). Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors. J Pharmacol Exp Ther 281, 10301037.
  • Lake KD, Martin BR, Kunos G & Varga K (1997b). Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension 29, 12041210.
  • Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA, Imperato A, Pedrazzini T, Roques BP, Vassart G, Fratta W & Parmentier M (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283, 401404.
  • Li J, Kaminski NE & Wang DH (2003). Anandamide-induced depressor effect in spontaneously hypertensive rats: role of the vanilloid receptor. Hypertension 41, 757762.
  • Liu J, Gao B, Mirshahi F, Sanyal AJ, Khanolkar AD, Makriyannis A & Kunos G (2000). Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem J 346, 835840.
  • Malinowska B, Kwolek G & Gothert M (2001). Anandamide and methanandamide induce both vanilloid VR1- and cannabinoids CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats. Naunyn Schmiedebergs Arch Pharmacol 364, 562569.
  • Matsuda LA, Lolait SJ, Brownstein MJ, Young CA & Bonner TI (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561564.
  • Mechoulam R, Fride E & Di Marzo V (1998). Endocannabionoids. Eur J Pharmacol 359, 118.
  • Mukhopadhyay S, Chapnick BM & Howlett AC (2002). Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. Am J Physiol 282, H2046H2054.
  • Munro S, Thomas KL & Abu-Shaar M (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 6165.
  • Nakano K, Sugawara M, Ishihara K, Kanazawa S, Corin WJ, Denslow S, Biederman RW & Carabello BA (1990). Myocardial stiffness derived from end-systolic wall stress and logarithm of reciprocal of wall thickness. Contractility index independent of ventricular size. Circulation 82, 13521361.
  • Niederhoffer N & Szabo B (2000). Cannabinoids cause central sympathoexcitation and bradycardia in rabbits. J Pharmacol Exp Ther 294, 707713.
  • Pacher P, Liaudet L, Bai P, Mabley JG, Kaminski PM, Virag L, Deb A, Szabo E, Ungvari Z, Wolin MS, Groves JT & Szabo C (2003). Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation 107, 896904.
  • Pacher P, Liaudet L, Bai P, Virag L, Mabley JG, Hasko G & Szabo C (2002a). Activation of poly (ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure. J Pharmacol Exp Ther 300, 862867.
  • Pacher P, Liaudet L, Mabley J, Komjati K & Szabo C (2002b). Pharmacologic inhibition of poly (adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure. J Am Coll Cardiol 40, 10061016.
  • Pacher P, Liaudet L, Soriano FG, Mabley JG, Szabo E & Szabo C (2002c). The role of poly (ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51, 514521.
  • Ralevic V, Kendall DA, Randall MD & Smart D (2002). Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: Roles in regulation of cardiovascular function. Life Sci 71, 25772594.
  • Ralevic V, Kendall DA, Randall MD, Zygmunt PM, Movahed P & Hogestatt ED (2000). Vanilloid receptors on capsaicin-sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteries. Br J Pharmacol 130, 14831488.
  • Randall MD, Harris D, Kendall DA & Ralevic V (2002). Cardiovascular effects of cannabinoids. Pharmacol Ther 95, 191202.
  • Ray AM, Benham CD, Roberts JC, Gill CH, Lanneau C, Gitterman DP, Harries M, Davis JB & Davies CH (2003). Capsazepine protects against neuronal injury caused by oxygen glucosae deprivation by inhibiting I(h). J Neurosci 23, 1014610153.
  • Szolcsányi J (2000). Are cannabinoids endogenous ligands for the VR1 capsaicin receptor Trends Pharmacol Sci 21, 4142.
  • Varga K, Lake KD, Huangfu D, Guyenet PG & Kunos G (1996). Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension 28, 682686.
  • Varga K, Lake K, Martin BR & Kunos G (1995). Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol 278, 279283.
  • Varga K, Wagner JA, Bridgen DT & Kunos G (1998). Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J 12, 10351044.
  • Wagner JA, Hu K, Bauersachs J, Karcher J, Wiesler M, Goparaju SK, Kunos G & Ertl G (2001a). Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. J Am Coll Cardiol 38, 20482054.
  • Wagner JA, Járai Z, Bátkai S & Kunos G (2001b). Haemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. Eur J Pharmacol 423, 203210.
  • Wagner JA, Varga K, Ellis EF, Rzigalinski BA, Martin BR & Kunos G (1997). Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature 390, 518521.
  • White R, Ho WS, Bottrill FE, Ford WR & Hiley CR (2001). Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br J Pharmacol 134, 921929.
  • Zahner MR, Li DP, Chen SR & Pan HL (2003). Cardiac vanilloid receptor 1-expressing afferent nerves and their role in the cardiogenic sympathetic reflex in rats. J Physiol 551, 515523.
  • Zygmunt PM, Andersson DA & Högestätt ED (2002). Delta 9-tetrahydrocannabinol and cannabinol activate capsaicin-sensitive sensory nerves via a CB1 and CB2 cannabinoid receptor-independent mechanism. J Neurosci 22, 47204727.
  • Zygmunt PM, Petersson J, Andersson DA, Chuang H-H, Sorgard M, Di Marzo V, Julius D & Högestätt ED (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400, 452457.